Features and Outcomes of Microcrystalline Arthritis Treated by Biologics: A Retrospective Study

OBJECTIVES: The usual treatments for crystal-associated arthritis are sometimes contraindicated; thus, new therapies against interleukin-1beta (IL-1) have been developed. We evaluated the characteristics of patients who received biological treatment for crystal-associated arthritis. PATIENTS AND MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Doaré, Elise, Robin, François, Racapé, Hélène, Le Mélédo, Guillaume, Orione, Charles, Guggenbuhl, Pascal, Goupille, Philippe, Gervais, Elisabeth, Dernis, Emmanuelle, Bouvard, Béatrice, Marhadour, Thierry, Coiffier, Guillaume, Saraux, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380607/
https://www.ncbi.nlm.nih.gov/pubmed/34218418
http://dx.doi.org/10.1007/s40744-021-00335-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380607/
https://www.ncbi.nlm.nih.gov/pubmed/34218418
http://dx.doi.org/10.1007/s40744-021-00335-7

Ejemplares similares